The neural addiction of cancer
- PMID: 37041409
- DOI: 10.1038/s41568-023-00556-8
The neural addiction of cancer
Abstract
The recently uncovered key role of the peripheral and central nervous systems in controlling tumorigenesis and metastasis has opened a new area of research to identify innovative approaches against cancer. Although the 'neural addiction' of cancer is only partially understood, in this Perspective we discuss the current knowledge and perspectives on peripheral and central nerve circuitries and brain areas that can support tumorigenesis and metastasis and the possible reciprocal influence that the brain and peripheral tumours exert on one another. Tumours can build up local autonomic and sensory nerve networks and are able to develop a long-distance relationship with the brain through circulating adipokines, inflammatory cytokines, neurotrophic factors or afferent nerve inputs, to promote cancer initiation, growth and dissemination. In turn, the central nervous system can affect tumour development and metastasis through the activation or dysregulation of specific central neural areas or circuits, as well as neuroendocrine, neuroimmune or neurovascular systems. Studying neural circuitries in the brain and tumours, as well as understanding how the brain communicates with the tumour or how intratumour nerves interplay with the tumour microenvironment, can reveal unrecognized mechanisms that promote cancer development and progression and open up opportunities for the development of novel therapeutic strategies. Targeting the dysregulated peripheral and central nervous systems might represent a novel strategy for next-generation cancer treatment that could, in part, be achieved through the repurposing of neuropsychiatric drugs in oncology.
© 2023. Springer Nature Limited.
Similar articles
-
Nerve input to tumours: Pathophysiological consequences of a dynamic relationship.Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188411. doi: 10.1016/j.bbcan.2020.188411. Epub 2020 Aug 21. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32828885 Review.
-
Neural Circuitries between the Brain and Peripheral Solid Tumors.Cancer Res. 2024 Nov 4;84(21):3509-3521. doi: 10.1158/0008-5472.CAN-24-1779. Cancer Res. 2024. PMID: 39226520 Free PMC article. Review.
-
Progenitors from the central nervous system drive neurogenesis in cancer.Nature. 2019 May;569(7758):672-678. doi: 10.1038/s41586-019-1219-y. Epub 2019 May 15. Nature. 2019. PMID: 31092925
-
The Neuroimmune Axis in the Tumor Microenvironment.J Immunol. 2020 Jan 15;204(2):280-285. doi: 10.4049/jimmunol.1900828. J Immunol. 2020. PMID: 31907270 Review.
-
The Adrenergic Nerve Network in Cancer.Adv Exp Med Biol. 2021;1329:271-294. doi: 10.1007/978-3-030-73119-9_15. Adv Exp Med Biol. 2021. PMID: 34664245
Cited by
-
Research trends on cancer neuroscience: a bibliometric and visualized analysis.Front Neurosci. 2024 Aug 29;18:1408306. doi: 10.3389/fnins.2024.1408306. eCollection 2024. Front Neurosci. 2024. PMID: 39268034 Free PMC article.
-
Attenuated sex-related DNA methylation differences in cancer highlight the magnitude bias mediating existing disparities.Biol Sex Differ. 2024 Dec 23;15(1):106. doi: 10.1186/s13293-024-00682-4. Biol Sex Differ. 2024. PMID: 39716176 Free PMC article.
-
Context-Dependent Regulation of Peripheral Nerve Abundance by the PI3K Pathway in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma.Cells. 2024 Jun 14;13(12):1033. doi: 10.3390/cells13121033. Cells. 2024. PMID: 38920662 Free PMC article.
-
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.Nat Commun. 2025 Mar 4;16(1):2195. doi: 10.1038/s41467-025-57293-9. Nat Commun. 2025. PMID: 40038334 Free PMC article. Clinical Trial.
-
What a wonderful world!Genes Dev. 2024 Oct 16;38(17-20):802-804. doi: 10.1101/gad.352278.124. Genes Dev. 2024. PMID: 39362781 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical